CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (14,649)	$ (52,403)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	38,872	13,791
Change in fair value of contingent consideration	(10,425)	(211)
Change in fair value of warrant liabilities	(57,337)	(39,215)
Loss on extinguishment of debt	1,428	13,225
Amortization of debt issuance costs	1,570	8,541
Non-cash lease expense	3,642	0
Stock-based compensation	31,600	3,680
Changes in operating assets and liabilities:
Accounts receivable, net	(67,557)	(6,441)
Other assets	7,158	(5,925)
Prepaid expenses and other current assets	(17,834)	(16,341)
Interest accrued due to sellers	100	957
Accounts payable and accrued expenses (Related parties comprised $1,331 and $111 for the six months ended June 30, 2022 and 2021, respectively)	(9,362)	14,426
Other liabilities (Related parties comprised $1,242 and $456 for the six months ended June 30, 2022 and 2021, respectively)	10,621	7,816
Net cash provided by (used in) operating activities	(82,173)	(58,100)
Cash Flows from Investing Activities:
Purchase of property and equipment (Related parties comprised $3,567 and $2,864 for the six months ended June 30, 2022 and 2021, respectively)	(20,431)	(7,730)
Acquisitions of subsidiaries including non-compete intangibles, net of cash acquired	(4,995)	(614,394)
Payments to sellers	(3,847)	(23,963)
Net cash provided by (used in) investing activities	(29,273)	(646,087)
Cash Flows from Financing Activities:
Business combination and PIPE financing	0	935,362
Payments of long-term debt	(3,222)	(402,572)
Debt issuance costs	(88)	(11,274)
Proceeds from long-term debt	0	295,000
Proceeds from delayed draw term loan	0	175,000
Repayments of delayed draw term loan	0	(2,350)
Proceeds from insurance financing arrangements	2,529	1,702
Payments of principal on insurance financing arrangements	(1,380)	(993)
Principal payments under finance leases	(679)	(64)
Repayment of equipment loans	(261)	(154)
Employee stock purchase plan withholding tax payments	(776)	0
Net cash provided by (used in) financing activities	(3,877)	989,657
Net increase (decrease) in cash, cash equivalents and restricted cash	(115,323)	285,470
Cash, cash equivalents and restricted cash at beginning of year	163,170	33,807
Cash, cash equivalents and restricted cash at end of period	47,847	319,277
Supplemental cash flow information:
Interest paid	27,670	11,925
Income taxes paid	82	0
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange of lease liabilities	50,297	0
Issuance of class A common stock for acquisitions	15,771	60,000
Contingent consideration in connection with acquisitions	0	9,600
Due to sellers in connection with acquisitions	3,533	295
Addition to construction in process funded through accounts payable	3,580	0
Humana Affiliate Provider clinic leasehold improvements	2,928	2,864
Employee stock purchase plan issuance	9,707	0
Capital lease obligations entered into for property and equipment	0	52
Equipment loan obligations entered into for property and equipment	$ 0	$ 183